2006The Chinese Journal of Clinical PharmacologyRequires access

Bioequivalence of zopiclone tablet in Chinese healthy volunteers

Si Tian

Open publisher page 1 citations

Abstract

Objective To study the relative bioavailability, pharmacoki-netic parameters and bioequivalence of zopiclone. Methods A single oral administration of 7. 5 mg test and reference zolpiclone tablet were given to 22 healthy male volunteers in randomized crossover study respectively. HPLC fluorescent detection was used to assay the concentration of zopiclone in human serum. The data were analyzed by 3P97 program. Results The pharmacokinetic parameters after a single oral administration of 7. 5 mg test and reference products were as follows: tmax were (0.89±0.31) and (1.03 ±0.33) h;Cmax were (20.26 ±4.88) and (20. 22 ± 4. 59) ng · mL-1; AUC0-t were (118. 57 ± 24. 50) and (117.84 ±25.47) ng · h · mL-1;t1/2 were (6.58 ±2. 10) and (6.99 ±2.65) h, respectively. Variance analysis and two one -side test were performed to parameters: Cmax,AUC0-t and AUC0→∞. The relatively bio-availability of single test tablet administration was (101. 5 ± 13. 8)%. Conclusion The two preparations were of bioequivalence.

About this research paper

What this paper is about

Objective To study the relative bioavailability, pharmacoki-netic parameters and bioequivalence of zopiclone. Methods A single oral administration of 7. 5 mg test and reference zolpiclone tablet were given to 22 healthy male volunteers in randomized crossover study respectively. HPLC fluorescent detection was used to assay the concentration of zopiclone in human serum. The data were analyzed by 3P97 program. Results The pharmacokinetic parameters after a single oral administration of 7. 5 mg test and reference products were as follows: tmax were (0.89±0.31) and (1.03 ±0.33) h;Cmax were (20.26 ±4.88) and (20. 22 ± 4. 59) ng · mL-1; AUC0-t were (118. 57 ± 24. 50) and (117.84 ±25.47) ng · h · mL-1;t1/2 were (6.58 ±2. 10) and (6.99 ±2.65) h, respectively. Variance analysis and two one -side test were performed to parameters: Cmax,AUC0-t and AUC0→∞. The relatively bio-availability of single test tablet administration was (101. 5 ± 13. 8)%. Conclusion The two preparations were of bioequivalence.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To study the relative bioavailability, pharmacoki-netic parameters and bioequivalence of zopiclone. Methods A single oral administration of 7. 5 mg test and reference zolpiclone tablet were given to 22 healthy male volunteers in randomized crossover study respectively. HPLC fluorescent detection was used to assay the concentration of zopiclone in human serum. The data were analyzed by 3P97 program. Results The pharmacokinetic parameters after a single oral administration of 7. 5 mg test and reference products were as follows: tmax were (0.89±0.31) and (1.03 ±0.33) h;Cmax were (20.26 ±4.88) and (20. 22 ± 4. 59) ng · mL-1; AUC0-t were (118. 57 ± 24. 50) and (117.84 ±25.47) ng · h · mL-1;t1/2 were (6.58 ±2. 10) and (6.99 ±2.65) h, respectively. Variance analysis and two one -side test were performed to parameters: Cmax,AUC0-t and AUC0→∞. The relatively bio-availability of single test tablet administration was (101. 5 ± 13. 8)%. Conclusion The two preparations were of bioequivalence.

Key concepts: Bioequivalence, Cmax, Bioavailability, Pharmacokinetics, Zopiclone, Crossover study, Pharmacology, Volunteer

Related papers

Back to paper searchBrowse research topicsOriginal source
Bioequivalence of zopiclone tablet in Chinese healthy volunteers — Research Paper | ScholarLens